Renin-angiotensin system inhibitors and troponin elevation in spinal surgery

被引:3
|
作者
McClendon, Jamal, Jr. [1 ]
Smith, Timothy R. [1 ]
Thompson, Sara E. [1 ]
Sugrue, Patrick A. [2 ]
Sauer, Andrew J. [3 ]
O'Shaughnessy, Brian A. [4 ]
Carabini, Louanne [5 ]
Koski, Tyler R. [1 ]
机构
[1] NW Mem Hosp, Dept Neurol Surg, Chicago, IL 60611 USA
[2] Washington Univ, Dept Orthoped Surg, St Louis, MO USA
[3] NW Mem Hosp, Div Cardiol, Dept Internal Med, Chicago, IL 60611 USA
[4] Howell Allen Clin, Nashville, TN USA
[5] NW Mem Hosp, Dept Anesthesiol, Chicago, IL 60611 USA
关键词
Angiotensin-converting enzyme inhibitors; Angiotensin receptor blockers; Hospitalization stay; Myocardial infarction; Spinal fusion; Troponin elevation; CONVERTING-ENZYME-INHIBITORS; VENTRICULAR SYSTOLIC DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; II-RECEPTOR BLOCKERS; HEART-FAILURE; CARDIOVASCULAR EVENTS; BLOOD-PRESSURE; HIGH-RISK; ESSENTIAL-HYPERTENSION;
D O I
10.1016/j.jocn.2013.10.019
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Renin-angiotensin system (RAS) inhibition by angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) has been shown to reduce cardiovascular mortality and non-fatal myocardial infarction (MI) in high-risk surgical patients. However, their effect in spinal surgery has not been explored. Our objective was to determine the effect of RAS inhibitors on postoperative troponin elevation in spinal fusions, and to examine their correlation with hospital stay. We retrospectively analyzed 208 consecutive patients receiving spinal fusions >= 5 levels between 2007-2010 with a mean follow-up of 1.7 years. Inclusion criteria were age >= 8 years, elective fusions for kyphoscoliosis, and semi-elective fusions for tumor or infection. Exclusion criteria were trauma and follow-up <1 year. Descriptives, frequencies, and logistic and linear regression were used to analyze troponin elevation (>= 0.04 ng/mL), peak troponin level, and hospital stay. The results featured 208 patients with a mean body mass index (BMI) 28.5 kg/m(2) who underwent 345 spinal fusions. ACEI/ARB were withheld the day prior to surgery in 121 patients with 11 patients noteworthy for intra-operative electrocardiogram changes, 126 patients with troponin elevation, and 14 MI identified prior to discharge. Multivariate logistic regression identified BMI (p = 0.04), estimated blood loss (p = 0.015), and preoperative ACEI/ARB (p = 0.015, odds ratio = 2.7) as significant independent predictors for postoperative troponin elevation. Multivariate linear regression showed preoperative Oswestry Disability Iridex (p = 0.002), unplanned return to operating room (p = 0.007), pneumonia prior to hospital discharge (p < 0.01), and preoperative ACEI/ARB to be associated with hospital stay. In patients with spinal fusions >= 5 levels, ACEI/ARB are independently associated with postoperative troponin elevation and increased hospital stay. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1133 / 1140
页数:8
相关论文
共 50 条
  • [21] The Decision to Interrupt Renin-Angiotensin System Inhibitors Before Surgery Should Be Individualized
    Ho, Anthony M. -H.
    Mizubuti, Glenio B.
    Phelan, Rachel
    Klar, Gregory
    Leitch, Jordan
    Cupido, Tracy
    Fleming, Melinda
    Azargive, Saam
    Arellano, Ramiro L.
    A & A PRACTICE, 2025, 19 (02) : e01911
  • [22] Should All Hypertensive Dialysis Patients Receive a Blocker of the Renin-Angiotensin System?
    Sinha, Arjun D.
    Agarwal, Rajiv
    CURRENT HYPERTENSION REPORTS, 2010, 12 (05) : 356 - 363
  • [23] Alternative Renin-Angiotensin System
    Bader, Michael
    Steckelings, U. Muscha
    Alenina, Natalia
    Santos, Robson A. S.
    Ferrario, Carlos M.
    HYPERTENSION, 2024, 81 (05) : 964 - 976
  • [24] The Role of the Renin-Angiotensin System in the Regulation of Erythropoiesis
    Vlahakos, Demetrios V.
    Marathias, Katerina P.
    Madias, Nicolaos E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 56 (03) : 558 - 565
  • [25] The past, present and future of renin-angiotensin aldosterone system inhibition
    Mentz, Robert J.
    Bakris, George L.
    Waeber, Bernard
    McMurray, John J. V.
    Gheorghiade, Mihai
    Ruilope, Luis M.
    Maggioni, Aldo P.
    Swedberg, Karl
    Pina, Ileana L.
    Fiuzat, Mona
    O'Connor, Christopher M.
    Zannad, Faiez
    Pitt, Bertram
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (05) : 1677 - 1687
  • [26] HEMODYNAMIC-EFFECTS OF INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM
    FOUADTARAZI, FM
    JOURNAL OF HYPERTENSION, 1994, 12 : S25 - S29
  • [27] Dual Blockade of the Renin-Angiotensin System for Cardiorenal Protection: An Update
    Arici, Mustafa
    Erdem, Yunus
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (02) : 332 - 345
  • [28] The role of the renin-angiotensin system inhibitors in malignancy: a review
    Yang, Ju
    Yang, Xi
    Gao, Ling
    Zhang, Jie
    Yi, Cheng
    Huang, Ying
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (03): : 884 - 897
  • [29] The role of the renin-angiotensin system inhibitors in malignancy: a review
    Yang, Ju
    Yang, Xi
    Gao, Ling
    Zhang, Jie
    Yi, Cheng
    Huang, Ying
    COGENT SOCIAL SCIENCES, 2021, 7 (01): : 884 - 897
  • [30] Cardiovascular effects of angiotensin A: A novel peptide of the renin-angiotensin system
    Coutinho, Danielle C. O.
    Foureaux, Giselle
    Rodrigues, Keyla D. L.
    Salles, Rodrigo L. A.
    Moraes, Patricia L.
    Murca, Tatiane M.
    De Maria, Marilda L. A.
    Gomes, Eneas R. M.
    Santos, Robson A. S.
    Guatimosim, Silvia
    Ferreira, Anderson J.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2014, 15 (04) : 480 - 486